Bharti Rathore MBBS
Voluntary Assistant Professor, Hematology & Medical Oncology
25 Buick St | (401) 456-2000
Hematology & Medical Oncology
Bharti Rathore, MD is a Hematologist Oncologist who also serves as an Associate Professor of Medicine at Chobanian and Avedisian School of Medicine. She was fellowship-trained in Hematology/Medical Oncology at Brown Medical School. She completed a residency in Internal Medicine at Memorial Hospital/Brown Medical School, following her graduation from J.N.M Medical College, Ravishankar University in India.
MBBS, Pt. Ravishankar Shukla University, 1995
Roda DJ, Albano B, Rathore B, Zhou L. Merkel cell carcinoma of the lower extremity: a case report. J Am Podiatr Med Assoc. 2014 Jul; 104(4):422-5. PMID: 25076088.Published on 6/25/2014
Roda DJ, Albano BJ, Rathore B, Zhou L. Merkel Cell Carcinoma of the Lower Extremity A Case Report. J Am Podiatr Med Assoc. 2014 Jun 25. PMID: 24964144.Published on 12/1/2010
Rathore B, Kadin ME. Hodgkin's lymphoma therapy: past, present, and future. Expert Opin Pharmacother. 2010 Dec; 11(17):2891-906. PMID: 21050034.Published on 2/4/2010
Rathore R, Birnbaum A, Rathore B, DiPetrillo T, Kennedy T, Ready N. Carboplatin with weekly docetaxel and ifosfamide in advanced head and neck cancers: a phase I Brown University Oncology Group dose escalation study (HN-93). Cancer Chemother Pharmacol. 2010 Nov; 66(6):1013-7. PMID: 20130878.Published on 9/1/2007
Evans D, Miner T, Iannitti D, Akerman P, Cruff D, Maia-Acuna C, Harrington D, Habr F, Chauhan B, Berkenblit A, Stuart K, Sears D, Kennedy T, Safran H. Docetaxel, capecitabine and carboplatin in metastatic esophagogastric cancer: a phase II study. Cancer Invest. 2007 Sep; 25(6):445-8. PMID: 17882656.Published on 8/1/2006
Dipetrillo T, Milas L, Evans D, Akerman P, Ng T, Miner T, Cruff D, Chauhan B, Iannitti D, Harrington D, Safran H. Paclitaxel poliglumex (PPX-Xyotax) and concurrent radiation for esophageal and gastric cancer: a phase I study. Am J Clin Oncol. 2006 Aug; 29(4):376-9. PMID: 16891865.